mshealthcare > Blog

Category: Blog

Your blog category

Posted on:

FOOD ALLERGY VS. FOOD INTOLERANCE : UNDERSTANDING THE DIFFERENCE

FOOD ALLERGY VS. FOOD INTOLERANCE : UNDERSTANDING THE DIFFERENCE

 A food allergy involves an immune system response that can be life-threatening, while a food intolerance is a digestive issue that is rarely served.

FOOD ALLERGIES

• Body system: immune system

• Mechanism: The body treats a harmless food protein as a dangerous invader and releases antibodies and histamine

• Severity: can be severe or life-threatening, leading to anaphylaxis , trouble breathing, or throat swealling

• Trigger amount: Even tiny trace amounts can trigger a rapid, dangerous reaction

• Common Triggers: peanuts, tree nuts ,milk, eggs ,soy ,fish ,shellfish ,wheat and sesame.

FOOD INTOLERANCES

• Body system: Digestive or metabolic system

• Mechanism: The body lacks the specific enzymes needed to properly break down or process certain food component

• Severity: Generally limited to digestive discomfort like Bloating, gas, stomach pain, or diarrhea. It is a not life-threatening.

• Trigger amount: often depends on portion size, small amounts can often be eaten without any symptoms.

• common Trigger: Lactose (dairy), gluten and fructose.

WHAT IS AN ALLERGY?

An Allergy is an overreaction of the body’s immune system to a normally harmless substance. An allergic reaction is an hypersensitivity reaction where the immune system overreacts to a normally harmless foreign substance. An allergic immune response happens when one immune system overreacts to a harmless everyday substance, treating it like a dangerous invader.

HOW THE IMMUNE SYSTEM RESPONDS TO AN ALLERGEN?

   When one have an allergy , the immune system mistakenly treats a harmless substance –like pollen, dust or pet danger –as a dangerous invader.

First Exposure (Sensitization)

• Mistaken Identity: An allergen enters the body, and the immune system incorrectly flags it as a threat.

• Antibody production: B-cells produce large amounts of a specialized antibody called immunoglobulin E (IgE) specific to that allergen

• Priming the cell: These IgE antibodies attach themselves to mast cells and basophils, which are alarm system cells located in the skin , airways and tissues . the body is now sensitized.

Subsequent Exposure (The Reaction)

• Re-counter: when one contact the allergen again, it binds directly to the IgE antibodies waiting the mast cells.

• Degranulation: This binding acts like a key in a lock, triggering the mast cells to burst open and release a flood of powerful inflammatory chemicals , most notably histamine .

• Symptoms appear: Histamine widens blood vessels and leaks fluid into tissues ,causing symptoms like a runny nose, sneezing , itchy or watery eyes ,hives or restricted airways.

WHAT DOES INTOLERANCE MEAN?

In Healthcare , intolerance means an abnormal physical reaction to a substance or an inability to endure physical activity ,which does not involve an immune system.

Types of intolerance

1. Medication or Drug intolerance

An adverse, non-allergic reaction to a medicine. It often causes side effects like nausea or dizziness at normal doses, but it does not trigger a dangerous immune response like anaphylaxis .

2. Food or nutrient intolerance

A digestive or metabolic difficulty in processing specific foods or ingredients . symptoms usually include bloating, gas or stomach pain and depend on how much of the food is eaten.

3. Activity intolerance

A lack of physiological or psychological energy . it means a person cannot finish everyday task or physical efforts without feeling extreme fatigue, pain or shortness of breath.

HOW INTOLLERENCE DIFFER FROM AN IMMUNE REACTION?

A food intolerance affects the digestive system and metabolism , whereas an immune reaction (food allergy) involves the immune system releasing antibodies to fight a perceived threat.

Key Differences

A) Body system involved

• Intolerance: limited to the digestive or metabolic system

• Immune reaction: involves the immune system reacting with IgE antibodies and releasing histamine

B) Severity

• Intolerance: causes discomfort but is never life threatening

• Immune Reactions: can cause severe, life-threatening anaphylaxis ,even from tiny amounts.

C) Amount eaten

• Intolerance: small amounts of the food can often be eaten without any major issues

• Immune reaction: even microscopic amounts can trigger a dangerous response

D) Timing of symptoms

• Intolerance: symptoms are often delayed by several hours.

• Immune reaction: symptoms typically appear rapidly within minutes to a couple of hours.

WHAT ARE THE KEY DIFFERENCES BETWEEN ALLERGIES AND INTOLLERANCES?

Key differences between allergies and intolerance are:

An allergy involves the immune system, whereas food intolerance does not involve the immune system at all.

A) Food allergies

• The immune response: The immune system mistakenly treats a harmless food protein as a dangerous invader. It creates immunoglobulin E(IgE) antibodies to attack it.

• Reactions: when one eat the food again, immune cells release chemicals like histamine. This causes rapid symptoms like hives, swelling, wheezing or life-therathing anaphylaxis .

• Triggers: Even a tiny amount can cause a severe reaction.

B) Food intolerances

• The digestive response: An intolerance is a digestive problem , not an immune reaction. It usually happens because the gut lacks a specific enzyme needed to breakdown a food component.

• Reactions: symptoms stay in the digestive tract and include bloating, gas , stomach cramps and diarrhea.

• Triggers: symptoms are rarely dangerous and usually depend on the portion size- eating a tiny bit might cause no trouble at all. Common examples include lactose and gluten sensitivity .

HOW ALLERGIES ARE DIAGNOSED?

Doctors diagnose allergy using a detailed medical history, physical exam and specific tests like skin pricks or blood work.

A) Medical history and physical Exam

• Clinical History :The doctor asks about your symptoms ,when they happen and what triggers them.

• Physical Exam: The doctor checks the nose, eyes, throat, skin and lungs

• Symptom diary: one may track ones daily reactions and potential exposures.

B) Common Allergy test

• Skin prick test : A provider pricks the skin with a with a tiny amount of an allergen to check for a raised, itchy bump within 20 minutes

• Blood test : A lab test measures specific IgE antibodies in the blood to see how the immune system reacts to certain substances

• Skin patch test : patches containing common contact allergens are placed on the back for 48 hours to check for skin reactions

• Supervised challenged : one swallow or inhale a tiny control dose of a suspected food or medication under direct medical supervision.

CONCLUSION

Managing allergies in everyday life requires a consistent , proactive routine to minimize symptom flare-up and improve the quality of life .

Key Takeaways:

• Identify triggers: know your specific allergens_ wheather pollen ,dust millets, pet danger, or certain foods through professional testing

• Envionmental conditions: use HEPA air purifiers, wash bedding weekly in hot water, and keep windows closed during high pollen seasons

• Consistent medication: take prescribed antihistamines or use nasal sprays regularly as directed by doctor, rather than only reacting after symptoms start.

• Have a action plan: Always carry emergency tools like epinephrine auto-injector if one have severe , life-threathing allergies.

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS THE MAIN DIFFERENCE BETWEEN AN ALLERGY AND AN INTOLERANCE?

A food allergy involves an immune system response, whereas a food intolerance involves the digestive system. One can be food intolerant without a food allergy , as the two conditions affect different parts of the body .

QUESTION: CAN AN INTOLLERANCE BECOME AN ALLERGY?

No , a food intolerance cannot morph or turn into food allergy because they involve completely different biological systems in the body. While an intolerance does not transform into an allergy, one can independently have or develop both conditions at the same time .

QUESTION: WHEN SHOULD YOU SEEK MEDICAL HELP FOR AN ALLERGIC REACTION?

Seek immediate emergency medical help or go to nearest emergency room if an allergic reaction can causes severe symptoms like troubling breathing, swelling of the lips, tongue or throat or dizziness.

REFRENCES:

1)https://en.wikipedia.org/wiki/Allergy.

 

Posted on:

BLOOD THINNERS (ANTICOGULANTS) : A COMPLETE GUIDE 

BLOOD THINNERS (ANTICOGULANTS) : A COMPLETE GUIDE

An anticoagulant is a substance or medication that prevents or slows down the clotting of blood , commonly referred to as blood thinner. It is a medication or chemical that slows down the body’s natural blood clotting process . People often called them ‘’blood thinners ‘’ but they do not actually make the blood thinner, instead ,they prevent harmful clots from forming or growing larger in the heart, veins and arteries.

                             Blood clotting is important because it prevents excessive blood loss and protects the body from harmful germs when a blood vessel is injured.

Why Clotting Matters

• Stops Bleeding: when one get a cut or scrape, blood vessel break. tiny blood cells called platelets stick together to plug the hole.

• Repairs Damage: special proteins in the blood form a strong mesh over the plug. This turns into a solid seal or scrab so the tissue can heal underneath.

• Blocks Germs: The tight mesh prevents bacteria and dirt from entering the open wound.

HOW ABNORMAL BLOOD CLOTS CAN CAUSE SERIOUS HEALTH PROBLEMS ?

Abnormal blood clots cause serious health problems by blocking blood flow to vital organs or breaking loose and traveling through the bloodstream to cause life-threatening blockages.

• How abnormal clots cause damage?

• Blocked circulation: when a clot forms inside a blood vessels , it narrows or completely stops the flow of oxygen-rich blood to surrounding tissues

• Tissue and organ Starvation: deprived of oxygen and essential nutrients, cells in the affected organ begin to malfunction or die , leading to permanent organ damage or failure.

• Embolization: A clot can break free from its original site and moves through the circulatory system until it gets trapped in a narrow vessel, cutting off blood supply downstream.

Major Health complications by location

• Lungs (pulmonary Embolism-PE): A clot from deep in the body travels to the lungs and blocks an arterial branch. This causes severe shortness of breath , sharp chest pain, rapid heart rate and can result in sudden death.

• Brain (stroke): A clot blocks blood flow to brain tissue ,leading to brain cell death . this causes neurological symptoms like sudden weakness ,speech difficulties , confusion and permanent disability.

• Heart (Heart Attack): A clot in a coronary artery cuts off blood flow to heart muscle, causing severe chest pressure ,pain radiating to arm or jaw and potential heart failure or death .

• Deep vein thrombosis (DVT) : clots form in DVT causing localized swelling, pain , warmth and redness with a constant risk of breaking off to the lungs.

HOW DO ANTICOAGULANTS WORK?

Anticoagulants are medications that slow down the body’s blood –clotting process to prevent new clots from forming or existing clots from growing . it works by interrupting the body’s coagulation cascade to slow down the formation of blood clots.

Anticoagulants interference with clot formation

  Anticoagulants interrupt this chain reaction instead of physically breaking down existing clots . different types targets different parts of the system:

• Enhancing Natural inhibitors (Heparin): medications like Heparin team up with a natural body protein called antithrombin to block active clotting factors ,primarily thrombin and factor Xa . this stops the conversion to fibrin.

• Blocking vitamin K (warfarin): medications like warfarin stops the body from activating vitamin k, which the liver needs to build functional clotting factors . without enough active factors, the chain reaction slows down drastically.

• Directly targeting Key factors (DOACs): modern direct oral anticoagulant target specific active molecules in the cascade –such as factor Xa or direct thrombin –to halt the formation of the fibrin meshwork.

Preventing existing clots from growing and reducing the formation of new clots

Anticoagulants prevent existing blood clots from growing larger and stop new clots for forming by slowing down the body’s blood-clotting process.

Anticoagulant work in the following ways:

• Targeting clotting factors: Blood clotting relies on proteins in the blood called clotting factors. Anticogulnts block or decrease the activity of these specific factors

• Halting the cascade: this blocking action stops a chain reaction leads to a solid blood clot

• Stopping new clot formation: because the clotting proteins cannot link together properly, new clots cannot easily form in the blood vessels.

• Stabilizing existing clots: Anticogulants do not dissolve or break apart a clot that is already there. Instead, they stop it from getting any bigger while one body’s natural healing system slowly breaks down the existing clot over time.

WHAT ARE THE TYPES OF ANTICOGULANTS?

Types of anticoagulant are:

1. Vitamin K Antagonists (VKAs)

• How they work: They block vitamin K , which your liver needs to make clotting proteins

Common example: Warfarin (COUNMADIN)

• Key detail: Require regular blood test (like INR) and a steady diet with consistent vitamin K levels.

2. Direct oral Anticoagulants (DOAC)

• How they work: they target specific clotting proteins directly without needing routine blood monitoring

• Direct Factor Xa inhibitors: Apixaban , rivaroxaban and edoxaban.

3. Heparins (injectable or IV)

• How they work: They activate a natural anti-clotting protein called antithrombin.

• Unfractionated Heparin: Given through an IV in a hospital for fast , short –term use.

• Low molecular weight heparin(LMWH): Given as a shot under the skin, such as Enaxoparin

4. Parental Direct thrombin inhibitor

• How they work: injectable drugs that attach directly to thrombin to stop clots

• Examples: Argatroban and bivalirudin often used in specific hospital procedures or complications like heparin-induced thrombocytopenia .

WHAT ARE THE COMMON USES OF ANTICOGULANTS?

Common uses of anticoagulants are:

1) Atrial fibrillation

Oral anticoagulants significantly reduce stroke and systematic embolism in patients with atrial fibrillation by a chambers.

2) Deep vein thrombosis (DVT)

Anticoagulants , commonly called blood thinners ,are the primary medical treatment used to stop a deep vein thrombosis (DVT) from growing and to prevent new blood clots from forming. Standard initial treatment usually last for at least 3 months to resolve the current clot. Some people need treatment for longer time or indefinitely if the risk of new clot returning is high.

3) Pulmonary embolism

Anticoagulants, commonly known as blood thinners , are the primary treatment for pulmonary embolism (PE) to stop existing clots from growing and prevent new ones from forming. Direct oral anticoagulants (DOACs) are the preferred first-line choice for most patients with a stable pulmonary embolism because they work quickly , require fixed dosing and do not need routine blood monitoring .

4) Prevention of blood clots after certain surgeries

Anticoagulant are the medications that slow down the body’s process of making clots to prevent dangerous blockages like deep vein thrombosis after major surgeris such as hip or Knee replacements.

WHAT THE BENEFITS OF ANTICOGULANT THERAPY?

Benefits of anticoagulant therapy are:

1) Reducing the risk of harmful blood clots

Anticoagulant therapy slows down the body’s natural clotting process to prevent dangerous blood clots from forming or growing larger . they work by targeting specific clotting factors in the blood so it takes much longer for a clot to form.

2) Preventing stroke in appropriate patients with atrial fibraliation

Using anticoagulants for stroke prevention in atrial fibrillation (AFib) requires careful risk assessment , and treating ‘’inappropriate’’ patients typically falls into two categories :overuse (giving anticoagulants to low-risk patients who don’t need them) and underuse( withholding treatment or giving too low a dose to high –risk patients out of fear of bledding).

CONCLUSION

Blood thinners are vital, life-saving medications that prevent dangerous clots from forming or growing, but they require strict medical supervision due to bleeding risks. They are prescribed to prevent strokes, heart attacks, and deep vein thrombosis in patients with heart conditions , abnormal rhythms like artrial fibrillation or post-surgery risk. Patient never stop taking these medications independently and should always report all supplements , foods and concurrent drugs to their doctor.

FREQUENTLY ASKED QUESTIONS (FAQs):

 QUESTION: WHAT IS AN ANTICOGULANT?

An anticoagulant is a substance or medication-commonly called a blood thinner-that prevents or slows down the coagulation processes of blood clotting. They work by blocking specific proteins in the not easily form. They also do not break down or dissolve existing clots, but they stop current clots from getting larger and keep new ones from forming.

QUESTION: WHAT ARE THE MOST COMMON ANTICOGULANTS?

The most common blood thinners or anticoagulant are:

• Apixaban (Eliquis): A popular modern pill taken twice daily that does not require routine blood testing

• Rivaroxaban ( xarelto): A once-daily pill similar to Equilis used to treat and prevent deep vein thrombosis and strokes

• Warfarin (counmadin,jantoven) :The traditional and long-standing oral option, which requires regular blood test to check one dosage level.

• Dabigataran (Pradaxa): An oral capsule that blocks a key molecule involved in forming clots.

• Heparin: A fast –acting injectable or IV medication used primarily in hospitals during surgeries or acute events.

REFRENCES:

1)https://my.clevelandclinic.org/health/treatments/22288-anticoagulants

2)https://medlineplus.gov/bloodthinners.htm◊l

Posted on:

PEGSTIM INJECTION FOR NEUTROPENIA : USES AND BENEFITS

 

PEGSTIM injection is a brand-name prescription medication containing Pegfilgrastim, which is a colony-stimulating factor used to help the body produced more white blood cells and lower the risk of severe infections during chemotherapy. It prevents chemotherapy-induced neutropenia by stimulating the bone marrow to rapidly produce neutrophils, a vital type of white blood cell needed to fight infections.

 

WHAT IS PEGSTIM INJECTION PFS?

PEGSTIM 6mg injection PFS is classified as a granulocyte colony-stimulating factor (G-CSF) hematopoietic agent.

Key classification:

  • Drug class: colony-stimulating factor/hematopoietic agent
  • Active ingredient: Pegfilgrastim (6mg/0.6ml)
  • Dosage form: PFS (pre-filled syringe ) for subcutaneous injection
  • Primary use: prevents severe neutropenia and infection risk in

Patients undergoing myelosuppressive chemotherapy for non-myeloid cancers.

  • Role in preventing chemotherapy –induced neutropenia: A PFS delivers a long-acting growth factor that stimulates the bone marrow to quickly make new white blood cells, preventing dangerous drops in neutrophils caused by myelosuppressive chemotherapy.
  • Mechanism of action: it prompts the bone marrow to produce, mature and release infection-fighting white blood cells (neutrophils ).

 

WHAT ARE THE USES OF PEGSTIM INJECTION?

Uses of PEGSTIM injection are:

1)Prevention of febrile neutropenia associated with chemotherapy

PEGSTIM injection is a long-acting colony –stimulating factor used once per chemotherapy cycle to prevent severe neutropenia and the risk of infection . it is a pegglated form of stimulating factor that stimulates the bone marrow to rapidly produce new neutrophils . Due to its larger molecular size, it stays in the body longer and clears out as neutrophil count recover, requiring only a single dose cycle instead of daily injections.

 

2)Reduction in the duration of chemotherapy-induced neutropenia

A single injection of PEGSTIM per chemotherapy cycle significantly reduces the duration of severe neutropenia and lowers the risk of febrile neutropenia compared to daily injections. A polyethylene glycol molecule is attached to filgrastim, which prevents rapid clearance by the kidneys . The drug stays in the blood and is cleared by the neutrophils, it decreases naturally as once neutrophils count recovers . one 6 mg injection per chemotherapy cycle replaces 10 to 11 daily injections of standard filgrastim.

 

3)Support of neutrophil recovery during appropriate cancer treatment

A PEGSTIM injection stimulates the bone marrow to produce infection-fighting ,white blood cells , specifically during cancer chemotherapy. It act like a natural growth factor (G-CSF) to help the body recover from low white blood cell count. It also prevents serious condition called febrile neutropenia it helps keep the chemotherapy on track without unnecessary dose delays.

 

4)Use according to oncologist treatment plan

PEGSTIM injection is used to prevent severe infections by helping the bone marrow make new white blood cells after myleosuppressive chemotherapy. Cancer drugs lower once count of neutrophils ,this medicine also lowers one risk of feer and dangerous infections. It is a lab-made protein that signals one bone marrow to produce white blood cells quickly. Usually given as a single 6 mg injection under the skin per chemotherapy cycle.

 

HOW PEGSTIM WORK?

PEGSTIM works by telling the bone marrow to make more white blood cells, specially neutrophils ,which protect the body from infections.

It works in the body in the following ways:

  • Stimulation of the G-CSF receptor

PEGSTIM stimulates the granulocyte colony-stimulating factor (G-CSF) receptor by binding directly to it through its protein component , which triggers cell growth and maturation signals in the bone marrow . the active protein part of PEGSTIM attaches to the specific G-CSF receptors located on the surface of immature blood cells . this binding turns on the inside of the cell , specifically activating  JAK-STAT pathway . the cell signal tell the bone marrow to multiply these progenitor cells and turn them into mature infection-fighting white blood cells called neutrophils.

  • Promotion of neutrophil production in the bone marrow

PEGSTIM promotes neutrophil production by acting as a long-acting artificial version of a natural growth factor that signals the bone marrow to manufacture infection-fighting white blood cells . the drug travels through the bloodstream to the bone marrow and bid to specific G-CSF receptors on the surface of immature precursor cells . This binding activates internal cell pathways that tell the immature cells to grow, divide and survive . it accerlates the transformations of stem cells into mature neutrophils and promotes the bone marrow to release them rapidly into the blood stream.

  • Increase in circulating neutrophil levels

PEGSTIM increases circulating neutrophil levels by binding to a specific receptors on bone marrow cells to stimulate their production ,maturation and release. It attaches to G-CSF on hematopoietic stem cells and myeloid precursor cells. It also triggers the rapid proliferation of neutrophil precursors cells in the bone marrow. It pushes the newely formed mature neutrophils out of the bone marrow and into the bloodstream. It also prolongs the lifespan of mature neutrophils by preventing their early cell death.

 

  • Long-acting effect compared with filgrastim

PEGSTIM requires only a single injection per chemotherapy cycle , whereas filgratism requires daily injections upto 14 days. PEGSTIM is cleared rapidly by the kidneys. Both drugs offered a similar overall ability to reduce severe neutropenia .

WHAT ARE THE BENEFITS OF PEGSTIM?

Benefits of PEGSTIM are :

  • Helps reduce the risk of chemotherapy- related neutropenia

PEGSTIM lowers the chance of febrile neutropenia by stimulating the body to make infection-fighting white blood cells called neutrophils. It act like a natural body signal to help bone marrow quickly produce neutrophils after harsh chemotherapy. Patient usually need only one injection per chemotherapy cycle instead of many doses.

2)Helps lower the risk of febrile neutropenia

PEGSTIM reduces the risk of febrile neutropenia by stimulating the bone marrow to produce infection-fighting white blood cells called neutrophils during cancer chemotherapy. It is a pegylated form of filgrastim that stays in the body longer, meaning it usually requires only a single injection per chemotherapy cycle. It significantly cut down the rate of neutropenia , hospital stays and infection-related deaths.

 

CONCLUSION

PEGSTIM act as a long-acting bone marrow stimulus that effectively decreases the duration of severe chemotherapyhttps://oncomshealthcare.com/living-with-prostate-cancer-treatment-diet-lifestyle-tips/comprehensive-guide-to-chemotherapy-and-cancer-care/ –induced neutropenia with a single injection per cycle. Its self-regulating clearance and predictable safety profile maintain cancer treatment intensity without neccessiting daily dosing. If effectively manages severe neutropenia and reduces febrile neutropenia risk through a single dose subcutaneous administration per chemotherapy cycle. Its self -regulating clearance profile and safety comparibilty to short-acting filgrastism offer a dependable alternative that eliminates multiple daily administrations.

 

FREQUENTLY ASKED QUESTIONS (FAQs) :

QUESTION: WHAT IS PEGSTIM INJECTION USED FOR?

PEGSTIM injection is used to lower the risk of severe infections in cancer patients receving chemotherapy  by stimulating bone marrow to produce more white blood cells.it treats and prevents neutropenia caused by non-myeloid cancer medicines. This help reduce infection risk and prevents delay in chemotherapy schedule. It is also used to improved survival in patient who have been exposed to myelosuppressive doses of radiation .

QUESTION: HOW DOES PEGFILFGRASTIM WORK?

Pegfilgrastim work by signaling the bone marrow to quickly make more neutrophils , which are white blood cells that fight infections. It is a manmade version of a natural protein one body makes called granuloyte colony –stimulating factor (G-CSF). It attaches ti immature cells in the bone marrow and triggers them to grow and mature into infection fighting neutrophils.

QUESTION: WHY CAN PEGSTIM CAUSE BONE PAIN?

PEGSTIM frequently causes bone pain because it rapidly stimulates the bone marrow to produce new white blood cells. It happens because the medicine stimulates one bone marrow to quickly make new white blood cells. Pain typically effects areas with high bone marrow activity, such as lower back pain,pelvis,  sternum and long bones .

REFRENCES:

1)https://www.1mg.com/drugs/pegstim-injection-110988?wpsrc=Google+Organic+Search

2)https://m.indiamart.com/proddetail/pegstim-6mg-pegfilgrastim-injection-26035051412.html

 

Posted on:

MYDEKLA 60 MG : A GUIDE TO HEPATITIS C TREATMENT

MYDEKLA 60 mg is a prescription antiviral medication containing Daclatasvir (60 mg) , used to treat chronic hepatitis C virus (HCV) infection in adults. It should be taken in the dose and duration as advised by the doctor . it should be taken with or without food , preferably at a fixed time. This medicine is part of the class of medicines known as HCV NS5A inhibitors. Before one start taking this medicine, it is essential to discuss the current health status with one doctor including any ongoing medications or pre-existing conditions . if one experience side effects while one experience side effects while on this medication , ensure to inform their doctor promptly. It is crucial to continue taking this medicine for the full duration prescribed by the doctor for the optimal results.

 

 

WHAT IS MYDEKLA 60 MG?

MYDELKA 60 mg tablets are classified as antiviral medications and specifically  as HEPATITIS C virus.

Key classification :

  • Pharmacological class: Direct-acting antiviral (DAA)
  • Specific sub-class: Hepatitis C virus NS5A (non-structural protein 5 A) inhibitor
  • Active ingredient : Daclatasvir
  • Prescription status: prescription –only medicine
  • Role of direct-acting antiviral therapy: MYDEKLA 60 mg is never used alone. It is always prescribed in a combination regime with other antiviral agents and is primarily indicated for treating adults with chronic HCV genotype 1 or genotype 3 infections. The goal of treatment is to prevent progressive liver scarring and lower the risk of liver failure.

 

WHAT ARE THE USES OF MYDEKLA 60MG?

Uses of MYDEKLA 60 MG are:

A)Treatment of chronic hepatitis C virus (HCV) infection

MYDELKA 60 mg tablet contains daclatasvir and is used with other antiviral drugs like sofosbuvir to treat chronic hepatitis C virus (HCV) infection in adults. It belongs to a group of medicines called NS5A inhibitors. It stops the hepatitis C virus from making copies of itself in the liver . it also lowers the amount of virus in the body and helps the immune system control the infection.

 

B)Used in combination with other antiviral medicines

MYDELKA 60 mg tablet contains daclatasvir and is used in combination with other antiviral medicines such as sofosbuvir, to treat chronic hepatitis C virus (HCV) infection in adults. One must always take MYDELKA with other anti-HCV drugs . the standard adult dose is 60 mg taken orally once daily with or without food. Treatment must be started and monitored by a doctor who knows how to manage chronic hepatitis C .

 

C)Considerations based on HCV genotype and patient factors

MYDELKA 60 mg is a pan-genotypic NS5A inhibitor , meaning it has antiviral across meaning it has antiviral activity across multiple strains, but it is primarily utilized for specific genotypes depending on regional guidance:

Consideration based on HCV Genotype

  • Genotype1 (1a and 1b) : Highly responsive. It is typically paired with sofosbuvir for 12 weeks in patients without advanced liver disease.
  • Genotype 3 : historically one of the more difficult genotypes to treat . It requires careful evaluation of liver fibrosis . patients without cirrhosis respond well to a 12-week regimen, while those with cirrhosis often require an extended duration or the addition of ribavirin.
  • Genotypes 2 and 4: can also be treated with this combination under specific expert guidance , with durations ranging from 12 to 24 weeks depending on the presence of liver scarring.

Consideration based on patient factors

  • Cirrhosis status: The presence and severity of liver cirrhosis significantly dictate how MYDELKA is prescribed :
  • A)No cirrhosis or compensated cirrhosis : Generally treated with MYDEKLA 60 mg plus sofosbuvir for 12 weeks
  • B)Decompenstated cirrohis : the liver is severely compromised . these patients require the addition of ribavirin to the MYDEKLA + sofosbuvir regime for 12 to 24 weeks to maximize the chances of a cure.

 

HOW MYDEKLA 60 MG WORKS?

MYDEKLA 60 mg works by blocking a vital viral protein called NS5A, which stops the hepatitis C virus from multiplying and spreading through the body. It works by the following ways:

1)Mechanism of action of Daclatasvir

DACLASTASVIR is a direct-acting antiviral medication that stops the hepatitis C virus (HCV) from multiplying by binding to and inhibiting the viral non-structural protein 5A (NS5A) . the medication stop the virus from forming new particles and breaks down the internal  structures that the virus used to build copies of itself inside liver cells.

 

2)Inhibition of HCV NS5A protein

The NS5A protein is an essential ,multi-functional component that the virus relies on to survive and multiply. By introducing 60 mg of MYDEKLA daily, the medication disrupts the viral lifecycle through a dual –action mechanism . beyond stalling replication, it stops the virus from packaging and assembling new viral particles. This creates inactive assembly platforms and prevents the virus from spreading to healthy cells.

 

3)Interference with viral replication

MYDEKLA 60 mg interferes with viral replication by blocking the NS5A protein, which the hepatitis C virus (HCV) needs to make copy of itself. The medicine attaches to the non-structural protein 5 A (NS5A), stopping its normal work in the viral replication complex.

 

4)Role in reducing HCV viral load

MYDEKLA 60mg reduces the HCV viral load by blocking a vital viral protein called NS5A to stop the virus from multiplying in the body. The Hepatitis C virus need a specific protein named non-structural protein 5A to copy itself. MYDELKA binds to and blocks this protein. By blocking NS5A, the medicine prevents the virus from creating new copies or building new viral RNA . without the abililty to multiply, the amount of virus in the blood drops rapidly over time. Consistent use helps clear the virus from the bloodstream and protects the liver from further damage .

 

CONCLUSION

MYDELKA 60 mg is an antiviral medicine containing daclastasvir that must always be taken with other drugs to succefully treat chronic hepatitis C virus infection. It blocks the hepatitis C virus from copying itself inside the body, this lowers the amount of virus in the blood and protects the liver. It should be taken as  prescribed by a Healthcare provider . it is neverbe used by itself.

 

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS MYDEKLA 60 MG USED FOR?

Mydekla 60 mg is an antiviral medicine used to treat chronic hepatitis C virus (HCV) infection in adults. It blocks a specific viral protein to stop the hepatitis C virus in the body and helps clear the infection from the blood.

 

QUESTION: HOW DOES DACLATASVIR WORK?

DACLATASVIR is a direct acting antiviral medication which stops NS5A protein, which stops the hepatitis C virus from multiplying in the body. It ataches directly to a specific part of the hepatitis C virus protein called NS5A. it changes the shape of a protein and breaks down these structures, beyond blocking replication, the drug prevents new viral particle from coming together and spreading to the other healthy cells.

REFRENCES:

1)https://www.1mg.com/drugs/mydekla-60-tablet-343746?wpsrc=Google+Organic+Search

2)https://oncohealthmart.com/product-details/440/mydekla-60mg-tablet/

 

Posted on:

PROGRAF 1MG CAPSULES FOR ORGAN TRANSPLANT REJECTION PREVENTION

PROGRAF 1 mghttps://oncomshealthcare.com/vitratraz-r-tablet-30-a-comprehensive-guide-to-its-uses-and-safety/ is a prescription oral capsule containing the active medicine tacrolimus, which lowers the body immune response to help prevent the rejection of transplanted organ. It stops the body from treating a new organ like a harmful invader. It also helps the new organ safe and work properly over time.

 

WHAT IS PROGRAF 1MG?

PROGRAF 1mg belongs to a class of medications called immunosuppressants and specifically function as a calcineurin inhibitor.

Key classification

  • Pharmacological class: calcineurin inhibitor
  • Therapeutic class: immunosuppressant
  • Active ingredient: Tarcolimus
  • Strength and dosage form :
  • A) strength: 1mg of anhydrous tacrolimus per unit
  • B) primary dosage form: oblong, hard gelatin code capsule
  • C) Other forms of Prograf: also manufactured in 0.5 mg and 5 mg capsule strengths, oral granules for suspension and an intravenous injection solution
  • Importance of maintaining consistent tacrolimus levels

PROGRAF 1MG plays a vital role in maintaining consistent blood levels because tacrolimus is a narrow therapeutic index (NTI) drug . this means the difference between a dose that is effective and one that is toxic exceptionally small. Because the body’s ability to absorb and process tacrolimus fluctuates heavily based on diet, lifestyle and other medications, the high precision afforded by the 1 mg capsule strength is essential for stabilizing these levels

 

WHAT ARE THE USES OF PROGRAF 1MG?

Uses of PROGRAF 1 mg are:

1)Prevention of kidney transplant rejection

PROGRAF 1mg is a prescription immunosuppressant medicine used with other drugs to help prevent the body from rejecting a kidney transplant. It works by clams the immune system so it does not attack the new kidney and also requires precise control because small changes in blood levels affect how well it works.

 

2)Prevention of liver transplant rejection

PROGRAF 1 mg used with other medicines to prevent the body from rejecting a newley transplanted liver. An immunosuppressant is a medicine that lowers the strength of ones body’s immune system. It works by stopping the specific immune cells from fighting the new liver. It also helps the body accept the new organ so it can stay healthy and work properly.

 

3)Prevention of heart transplant rejections

PROGRAF 1mg contains tacrolimus , an immuosuppresant used with other medications to prevent the body from rejecting a new heart. It works by suppressing the immune system to stop white blood cells from attacking the transplanted heart . it also helps the body accept the new organ so it can function normally. Doctors run regular blood test to check drug levels and kidney function.

 

4)Use with other immunosuppressant medicine as prescribed

PROGRAF 1mg is an immunosuppressant prescribed alongside other anti-rejection medicines to prevent the body from rejecting a transplanted organ.

Purpose of combination therapy

  • Organ protection: it lowers once immune systems activity so it does not attack ones new kidney, liver or heart.
  • Synergy: Doctors combine PROGRAF with other agents to effectively protect the graft while minimizing individual drug toxicities

HOW PROGRAF 1 MG WORKS?

PROGRAF 1mg works by blocking a calcium-dependent protein inside white blood cells called Calcineurin. It suppresses T-cells by blocking calcineurin, the medicine stops T-cells from activating , which normally attack foreign tissues but the drug stops them from recognizing the new organ as a threat . it works in the following ways:

  • Mechanism of action of tacrolimus

Tarcolimus suppresses the immune system by binding to an intracellular protein to block calcineurin, which stops T-lymphocyte activation and cytokine production.

Cellular and molecular steps

  1. Binding to FKBP-12: tacrolimus enters t-cells and binds to the immunophilin FK506- binding protein (FKBP-12)
  2. Inhibition of calcineurin : The resulting tacrolimus-FKBP-12 complex binds to and inhibits calcineurin, a calcium-and calmodulin-dependent phosphatase.
  3. Blocking NFAT Dephosphorylation: Normally , calcineurin dephosphorylates the neuclear factor of activated T-cell (NFAT) , allowing it to enter the cell nuclease . tacrolimus prevents this dephosphorylation step.
  4. Suppressing cytokine Transcription: without active NFAT in the nucleus , the transcription of critical growth factors and pro-inflammatory cytokines is severly impaired.
  5. Overall effect: Deprived of IL-2 and other vital signals, T-lymphocytes fail to activate and proliferate , reducing cell-mediated immune and inflammatory responses.
  • Suppression of immune response against transplanted organs

PROGRAF 1mg is a potent immunosuppressant medication prescribed to prevent the body from rejecting a transplanted organ. Suppressing the specific cellular immune response prevents the body’s  immune system from recogonizing the donar organ as foreign and attacking it.

 

WHAT ARE THE BENEFITS OF PROGRAF 1 MG?

Benefits of PROGRAF 1mg are:

  • Helps prevent organ rejection

PROGRAF 1mg is a prescription immunosuppressant medicine used with other drugs to help prevent the body from rejecting a transplanted kidney, liver , heart or lung. It works by blocking an enzyme called calcineurin

 to stop the immune systems T-cells from activating. It also calms the defense system so it does not treat the new organ as a foreign invader and attack it.  

  • Supports transplanted organ function

PROGRAF 1mg used alongside other drugs to prevent organ rejection after kidney, liver , heart or lung transplants. It works by blocking calcineurin, a protein needed to activate white blood cells that attack foreign tisues .  By lowering the immune response, it helps one’s body accept and support the function of a transplanted organ .

 

  • Helps maintain graft health

PROGRAF 1mg prevents rejection after a kidney, liver ,heart or lung transplant. It works by lowers the activity of T and B white blood cells so the body does not attack the new organ. It also helps the body to accept donor organs if it belonged there, supporting long-term organ function.

 

  • Supports long-term transplant management

PROGRAF 1mg calms the immune system so it does not attack the new organ. Doctors use it continuously to keep organ transplants safe over time. The 1mg capsule size helps patients match exact prescribed 1 mg targets set by their care team.

 

 

CONCLUSION

 

PROGRAF 1mg is a vital immunosuppressant medication used to prevent organ rejection in patients who have received a kidney, liver or heart transplant. It works by blocking the activity of calcineurin to suppress T-cell activity, which stops the immune system from attacking the new organ. The dosage require precise management and regular blood tests to maintain safe, effective drug levels in the body.

 

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS PROGRAF 1MG USED FOR?

PROGRAF 1mg is an immunosuppressant prescription medication used to prevent the body from rejecting a newly transplanted organ such as a kidney, heart or liver. It contains the active drug tacrolimus . it belongs to a group of medicines that weaken the immune system, it also stops the  immune cells from attacking and trying to reject the new transplanted organ.

 

QUESTION: HOW DOES TARCOLIMUS PREVENT ORGAN REJECTION?

Tarcolimus prevents organ rejection by suppressing the immune system ,  specifically by blocking white blood cells called T-lymphocytes from attacking the transplanted organ. It binds to an intracellular protein known as FKBP-1, which blocks an enzyme called calcineurin which is necessary for immune cell activation.  blocking calcineurin stops T-cells from sending chemical signals .

 

QUESTION: CAN PROGRAF 1MG BE TAKEN WITH FOOD?

PROGRAF 1mg can be taken either with or without food , but one must be completely consistent and take it the exact same way every single day.

REFRENCES:

1)https://www.1mg.com/drugs/prograf-1mg-hard-capsule-323059?wpsrc=Google+Organic+Search

2)https://www.truemeds.in/medicine/prograf-1-mg-capsule-10-box-of-5-tm-cacr1-009509

Posted on:

MAXILIV 500 MG TABLETS: COMPOSITION, USES AND SAFETY INFORMATION

 

MAXILIV 500 mg is a prescription nutritional supplement that contains reduced glutathione (500 mg) s its active ingredient . it act as a hepatoprotective agent and antioxidant to manage liver disorders and oxidative stress. It helps manage fatty liver, liver fibrosis and alcoholic cirrhosis by protecting liver cells from toxin-induced injury. It also supports recovery in acute and chronic liver conditions, including liver damage related to HIV/HCV co-infections. It also neutralizes harmful free radicals and assist the liver in breaking down metabolic waste and harmful substances.

 

WHAT IS MAXILIV 500 MG?

MAXILIV 500 mg is classified as a nutraceutical and antioxidant dietary supplement containing L-glutathione and its active ingredient.

Key classification:

  • Therapeutic category : Hepatoprotective agent (liver health supplement ) and cellular antioxidant
  • Active component: Reduced Glutathione 500 mg per tablet
  • Manufacturer : zuventus healthcare ltd.
  • Primary Uses : used to support liver detoxification, manage nutritional or glutathione deficiencies , and address conditions such as alcoholic fatty liver disease, liver cirrhosis and hepatitis.
  • Role in disease management: it helps manage alcoholic fatty liver , fibrosis, and cirrhosis by neutralizing free radicals and protecting liver cells from alcohol-induced injury . it also supports liver tissue repair and helps reduce inflammation during acute or chronic liver conditions. It assist the body and liver in breaking down harmful toxins ,chemicals and reactive oxygen species.

 

WHAT ARE THE USES OF MAXILIV 500 MG

Uses of MAXILIV 500 mg are:

1)Approved medical conditions: MAXILIV 500 mg contains reduced glutathione for and act as a liver-protecting supplement to manage cellular damage and nutritional deficiencies . it works by acting as a natural antioxidant made of three amino acids and protects body cells from harmful oxidative stress, it also assist in breaking down toxins and repairing tissues. Approved medical conditions are:

2)Alcoholic liver disease: helps manage fatty liver, fibrosis and liver scarring caused by heavy alcohol use .

A)Hepatitis: supports recovery during liver inflammation.

  1. )HIV and HCV co-infection: manages secondary liver damage in patients carrying both HIV and Hepatitis C.
  2. )Gastritis: Helps soothe inflammation of the stomach lining
  3. )Glutathione Deficiency: restores levels when diet alone does not provide enough .

2) conditions for which it may be prescribed :

MAXILIV 500 mg tablets condition reduced glutathione an important antioxidant naturally produced in the liver, and are prescribed to support cellular health and protect the liver from oxidative damage.

Role in prescribed conditions:

MAXILIV act as a hepatoprotectant and is used in the management of several conditions:

A)Alcoholic liver disease

Helps manage fatty liver, liver fibrosis, and alcoholic liver cirrhosis by reducing oxidative stress caused by alcohol breakdown

A)Hepatitis and chronic liver illness

Assist in supporting metabolic function and cellular regeneration in damaged liver tissues

B)Liver damaged from HIV/HCV co-infection: used as a adjunctive nutritional support to help mitigate oxidative injury in patients dealing with viral co-infections.

  1. )Gastritis : sometimes included to help manage inflammation of the stomach lining.
  2. General Detoxification and oxidative stress: helps the body and liver neutralize free radicles and break down toxins.

3) use alone or with other medicines, where appropriate

MAXILIV 500 mg tablets can be used either alone or with other medications, depending on the specific liver condition being treated .

A)Using MAXILIV alone

  • Liver support: it is often prescribed on its own as a primary or supplementary antioxidant to manage conditions like alcoholic fatty liver disease , liver fibrosis or early cirrhosis.
  • Deficiency management: Taken alone when the body has low dietary intake or an increased need for glutathione
  • B).Using MAXILIV with other medicines
  • Combination therapy: Doctors may combine with other live-protecting agents, vitamins or specific treatments if one are managing complex conditions like viral hepatitis or HIV/HCV co-infections
  • Potential interactions: certain substances like vitamin K, vitamin B12, calcium pantothenate, and antihistamines can affect how the body absorbs or utilizes glutathione. One always share a complete list of their current drugs and supplements with their doctor.

HOW MAXILIV 500 MG WORKS?

MAXILIV 500 mg tablet works by providing a high dose of glutathione , a powerful antioxidant that neutralizes harmful free radicles and protects cells from oxidative stress.

How it works

  • Cellular Defense: Glutathione gives a negative charge to unstable molecules and free radicles, stopping them from damaging cell membranes and DNA .
  • Liver protection: it helps the liver bind to heavy metals and toxins, converting them into water-soluble forms so the body can easily flush them out.
  • Tissue Repair: it aids in tissue building , protein synthesis and immune system maintainance.

Mechanism of action

  • Antioxidant Defense: Glutathione neutralizes harmful free radicals and reactive oxygen species ,reducing oxidative stress that can damage liver cells
  • Detoxification : it binds to toxins, drugs, and heavy metals ,helping liver break them down and eliminate safely from the body.
  • Cellular repair: it assists in tissue building ,cellular maintenance and regeneration of other essential antioxidants like vitamin C and E.

Hepatoprotection: by lowering toxin-induced stress, it prevents structural damage to the liver tissue and supports overall metabolic function in conditions like fatty liver and alcoholic liver disease.

Effect on underlying disease progression

MAXILIV 500 MG contains reduced glucathoine an antioxidant that help reduce oxidative stress and protect liver cells to potentially slow the progression of underlying liver diseases. It effect disease progression by the following ways:

  • Reduces oxidative stress: Glutathione neutralizes harmful reactive molecules that cause cellular injury in the liver.
  • Supports liver repair: it aids in tissue repair and cellular regeneration for conditions like fatty liver, fibrosis and early cirrhosis.
  • Targets inflammation: clinical benefits depend on the disease stage, research shows it most effective at managing active inflammation rather than reversing permanent structural scarring.

How it produces therapeutic benefits?

MAXILIV 500 mg tablets produce therapeutic benefits by supplying reduced glutathione , which act as a strong antioxidant to protect cell and supports liver health .

Key therapeutic benefits

  • Antioxidant action: fights harmful free radicles and lowers oxidative stress across body tissues.
  • Liver protection: act as a hepato-protectant to help detoxify ,maintain and repair liver cells
  • Immune support: Assists in maintaining the balance of white blood cells for better cellular defence

 

CONCLUSION

MAXILIV 500 mg tablet contains L-glutathione, a powerful antioxidant that helps protect liver cells from oxidative damage and supports natural detoxification. It as a hepatoprotective supplement to restore gluthathione levels in the body. It is prescribed for managing alcoholic liver diseases , fatty liver ,liver cirrohosis and gastritis. It is generally well tolerated ,though mild side effects like loose stools, or nausea can occur . always use under medical supervision.

 

FREQUENTLY ASKED QUESTIONS(FAQs):

QUESTION: WHAT IS MAXILIV 500 MG USED FOR?

MAXILIV tablet is a nutritional supplement containing 500 mg of glutathione that is primarily used to protect the liver health and manage liver diseases. It protects and repairs liver cells damaged by long-term alcohol use . it also helps lower inflammation and oxidative stress in the liver

QUESTION: HOW DOES MAXILIV 500MG WORK?

MAXILIV 500 mg works by delivering a high dose of l-glutathoine , a natural antioxidant that neutralizes harmful free radicles and reduces oxidative stress to protect and repair liver cells.

 

QUESTION: HOW SHOULD MAXILIV 500 MG BE TAKEN?

MAXILIV 500 mg be taken with or without food, swallow whole with a glass of water .take it consistently as directed by a healthcare professional for the best results.

REFRENCES:

1)https://www.1mg.com/otc/maxiliv-glutathione-tablet-for-adults-otc318116?wpsrc=Google+Organic+Search

2)https://www.apollopharmacy.in/otc/maxiliv-tablet?srsltid=AfmBOopfBIepwl82cvOp4Pq_QNr5UUl25k0RhtfUqFH5tH7fwS1wprsb

3)https://oncohealthmart.com/product-details/137/maxiliv-500mg-tablet/

 

 

 

 

 

 

Posted on:

HEPBEST 25 MG TABLETS: IMPORTANT INFORMATION FOR PATIENTS 

      HEPBEST 25 mg is a prescription antiviral tablet containing 25 milligrams of tenofovir alafenamide, used to treat long-term hepatitis –B infection. It belongs to a group of medicines called nucleoside reverse transcriptase inhibitors (NRTIs). It blocks specific 3enzyme that virus needs its copy its genetic material.

WHAT IS HEPBEST 25 MG ?

HEPBEST 25mg is classified as a nucleotide reverse transcriptase inhibitor(NTRIs) and belongs to an antiviral therapeutic drug class.

Key classification: 

• Pharmacological category : Nucleotide analogue/ Nucleoside and nucleotide reverse transcriptase inhibitor.

• Therapeutic class: Antiviral medication for systematic use.

• Active ingredient: Tenofovir alafenamide (25 mg)

• Primary indication: Treatment of chronic hepatitis B virus (HBV) infection in adults and adolescent.

• Importance of consistent treatment : Taking HEPBEST 25 mg everyday is essential to keep the virus from multiplying, lower ones viral load, and prevent severe liver damage. Consistency matters due to the following reasons:

A) Stops Virus Growth: Missing doses allows the virus to start copying itself again.

B) Protects ones liver: consistent treatment lowers the risk of long-term scarring, inflammation , and liver failure

C) Prevents Drug resistance: skipping pills can make the virus resistance to treatment, meaning the medicine may stop working.

D) Reduce long-term risk

Regular use helps keeps one immune system strong and delays disease progression.

WHAT ARE THE USES OF HEPBEST 25 MG?

Uses of HEPBEST 25 mg are:

1) Treatment of chronic hepatitis B virus (HBV) infection

HEPBEST 25 mg is a prescription antiviral medication used for long-term management of chronic hepatitis B virus (HBV) infection in adults and adolescents . the medication act as a nucleotide reverse transcriptase inhibitor (NRTI) , which targets liver cells to inhibit the enzyme necessary for the virus to replicate its DNA, Thereby reducing the multiplication of hepatitis B virus.

2) Used in appropriate adults and adolescents according to prescribing guidelines

HEPBEST 25 mg is fully indicated an widely considered appropriate for adolescent under current prescribing guidelines. Global regulatory bodies have approved this 25 mg daily dosing for the treatment of chronic hepatitis B virus(HBV) infection in pediatric patients .

Clinical criteria

a) Age and weight thresholds: while it was initially approved only for adults and adolescents aged 12 years and older weighing 35 kg, clinical guidelines have expanded.

b) Safety profile : TAF was specifically developed and priotrized for adolescent over older formulations because it carries a significantly lower risk of bone density loss and kidney toxicity , which is vital during an adolescent growth spurts.

c) Inappropriate use scenario : using this medication would only be deemed ‘’inappropriate’’ if the patient is under 6 years old , weigh less than 25 kg ,has severe decomposed liver disease, or has an untreated HIV co-infection .

3) Role in reducing HBV Replication

HEPBEST 25mg contains tenofovir alafenamide (TAF),which suppresses hepatitis B virus (HBV) replication by inhibiting the viral reverse transcriptase enzyme and terminating the viral DNA chain. It works by the following ways:

a) Prodrug conversion: TAF enters liver cells efficiently and converts into its active form , tenofovir diphosphate.

b) Enzyme inhibition: it blocks the viral DNA polymerase /reverse transcriptase needed for the hepatitis B virus to multiply.

c) Chain termination :it integrates into the viral DNA strand and stops the formation of new copies ,dropping the viral load in the blood.

4) Importance of monitoring liver health during treatment

Monitoring liver health during HEPBEST 25 mg treatment is essential to track how well the antiviral medicine controls the hepatitis B virus and to catch rare, severe liver or metabolic complications early.

Monitoring matters because of the following reasons:

a) Tracks treatment success: Blood test measure viral load and liver enzymes to see if the virus replication is slowing down and liver function is improving.

b) Detects severe reactions: Although rare, the medication can uncommonly cause serious liver distress,hepatomegaly, or lactic acidosis

c) Catches flare Early: stopping the medicine abruptly or undergoing changes in viral activity can cause severe acute flare-ups of hepatitis .

d) Prevents Added strain: Doctors advise avoiding alcohol during therapy because alcohol combined with medication sharply raises the risk of severe liver injury.

What test are typically done

a) Liver function test(LFT) : Blood panels check enzyme levels to assess ongoing inflammation or recovery

b) Viral load and Markers: periodic test measure HBV DNA and related antigens /antibodies to confirm the virus remain suppressed

c) Kidney Function test : Because tenofovir is processed through the body, renal function is regularly checked alongside liver markers.

HOW HEPBEST 25 MG WORKS?

                           HEPBEST 25 mg works by stopping the hepatitis B virus from multiplying inside the body. It contains tenofovir alafenamide, which belongs to a group of medicines called nucleotide reverse transcriptase inhibitors (NTRIs). It targets a specific enzyme that the virus needs to make copies of its genetic material. By blocking the enzyme, the medicine prevents the virus from growing and spreading, which lowers the amount of virus in the blood. It works by the following ways:

• Mechanism of action of Tenofovir alafenamide

Tenofovir is a nucleotide analog reverse transcriptase inhibitor (NtRI) . inside the body, it turns into an active form called tenofovir diphosphate . this active form blocks viral enzymes needed for multiplication by competing with natural building blocks, which stops the genetic chain from growing and halts viral replication.

• Inhibition of HBV DNA POLYMERASE/REVERSE TRANCRIPTASE

HEPBEST 25 mg contains tenofovir alafenamide, which inhibits hepatitis B virus (HBV) replication by turning into an active form that blocks viral DNA polymerase and reverse transcriptase. The medicine enters the liver cells directly . inside the cells, enzymes convert the drug into tenofovir disphosphate. This active metabolite target the HBV DNA polymerase and reverse transcriptase enzyme . the drug inserts itself into the viral DNA strand, causing chain termination and stopping the virus from multiplying.

CONCLUSION

HEPBEST 25 mg is an effective prescription medication for chronic hepatitis B that works by inhibiting viral multiplication, it offers a superior safely profile with fewer renal and bone side effects compared to older treatments.

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS HEPBEST 25 MG USED FOR?

HEPBEST 25mg is an chronic antiviral medication used to treat chronic hepatitis B virus (HBV) infection in adults and adolescents. It stops the hepatitis B virus from multiplying in the body, which lowers the amount of virus in the blood.

QUESTION: CAN HEPBEST CURE HEPATITIS B?

HEPBEST does not completely cure hepatitis B , but it is a highly effective medication used to long-term manage the virus. It stops the hepatitis B virus from multiplying , which lowers the viral load in the blood to highly manageable or even undetectable levels.

QUESTION: DOES HEPBEST EFFECT KIDNEY FUNCTION?

HEPBEST has a safer profile and rarely harm the kidneys compared to older treatment like tenofovir disoproxil fumarate (TDF).

REFRENCES:

1)https://www.1mg.com/drugs/hepbest-tablet-396439?wpsrc=Google+Organic+Search

2)https://www.apothecare.in/products/hepbest-25mg-tablet-1

Posted on:

COMPLETE GUIDE TO RNOCEL 100,00IU  INJECTION PFS

RENOCEL 100,000 IU injection is a prescription medication containing epoetin alfa, a man-made protein that tells the bone marrow to make more red blood cells. It treats low red-blood cell count (anemia) caused by chronic kidney disease or specific HIV medications.

 

WHAT IS RENOCEL 100,000 IU INJECTION?

RENOCEL 100,000 – IU injection belongs to a class of medications called erythropoiesis stimulating agent (ESA) .

Key classification:

  • Pharmacological class: Erythropoiesis stimulating agent (ESA) /recombinant human erythropoietin.
  • Active ingredient: Epoetin alfa
  • Primary function: it acts like the natural protein made by the kidneys to stimulate the bone marrow to produce more red blood cells.
  • Medication Type: prescription-only (Rx)
  • manufacturer : INTA’s pharmaceuticals

 

WHAT ARE THE USES OF RENOCEL 100,000 IU?

Uses of RENOCEL 100,000 IU are:

1) Management of Anaemia associated with chronic kidney disease

RENOCEL 100,000 IU contains Epotein Alfa, an erythropoiesis –stimulating Agent (ESA) used under strict medical supervision to treat severe anaemia associated with chronic Kidney disease (CKD) . It works in the following ways:

  • Replaces a missing hormone: Healthy kidneys make erthyopoietin, a hormone that tells the bone marrow to make red blood cells . Damaged kidneys cannot make enough of this hormone, leading to anaemia.
  • Stimulates production: Epoetin Alfa acts like natural erythropoietin to boost red blood cells counts, improve energy and reduces weakness or the need for blood transfusions.

 

2)Treatment of certain types of anaemia where approved

EPOETIN alfa is an ESA used to treat specific types of anaemia by signalling the bone marrow to create more red blood cells .

  • Chronic kidney Disease (CKD): Replaces the natural hormone that damaged kidneys fail to make adequately , helping patients on or off dialysis.
  • Cancer  chemotherapy: corrects low red blood cell counts caused by specific cancer treatments , reducing fatigue and transfusion needs.
  • HIV therapy: Treats anaemia triggered by certain antiviral medications like zidovudine.
  • Surgical prep: Lowers the necessity for red blood cell transfusion in patients undergoing major,non-cardiac elective surgeries.
  • 3)Reduction of transfusion requirements in appropriate patients

RENOCEL 100,00 IU is an ESA used to stimulate the bone marrow to produce red blood cells, thereby reducing the requirement for allogenic RBC transfusions in appropriate patients.

4)Appropriate patient Groups

a)Chronic kidney disease (CKD)

Patients with severe anaemia due to damaged kidneys that fail to produce adequate natural erythropoietin.

B)Cancer chemotherapy

Patients experiencing chemotherapy –induced anaemia where red blood cell production is suppressed

 

C)Surgical settings

Patients at high risk for perioperative blood loss undergoing major elective, noncardiac, and nonvascular surgeries .

D)HIV therapy 

developing anaemia secondary to anti-viral medications like zidovudine.

 

4) Use according to underlying cause of anaemia and medical assessment

RENOCEL 100,000 IU is a high-strength erythropoiesis –stimulating agent used to treat severe anaemia by signalling the bone marrow to produce more red blood cells.

  • Underlying causes of Anaemia treated
  • A)Chronic kidney Disease (CKD)

Replaces the natural erythropoietin hormone that damaged fail to make

B)Cancer chemotherapy

Counters bone marrow suppression caused by anti-cancer drugs.

C)HIV therapy

Treats anaemia triggered by specific antiviral medications like Zidovudine.

 

  • Medical Assessment and safety requirements

 

A)Iron status check

Doctors must test iron stores before and during treatment because the body needs adequate iron to build new red blood cells

 

B)Blood pressure monitoring

High doses can raise blood pressure , hypertension must be controlled before starting.

C)Strict supervision

High-strengths vials require precise dosing calculated by a specialist to avoid dangerous risks like blood clots or rapid blood pressure spikes.

 

HOW RENOCEL WORKS?

 

RENOCEL 10000 IU injection works by replacing a natural protein called erthyopoeitin to stimulate the bone marrow to produce more red blood cells. It works by the following ways:

  • Mechanism of action:

A) Replaces the natural hormone: it contains Epoetin Alfa, a man-made version of erythropoietin hormone normally produced by healthy kidneys.

B) Binds to receptors: The medicine targets and binds to specific erythropoietin receptors located on the red blood cells inside the bone marrow.

C) Stimulates growth and maturation:

This activation triggers the division, growth and maturation of these precursors cells into healthy, functional red blood cells.

D) improves oxygen transport : increasing the red blood cell count raises haemoglobin levels, which enhances the blood’s capacity to carry oxygen from the lungs to tissues and organs throughout the body.

  • Stimulation of erythropoietin receptors

RENOCEL 10000 IU injection contains epotein alfa, which acts as an erythropoiesis –stimulating agent by binding to and activating erythropoietin receptors in the bone marrow. It works in the following ways:

A)Receptor activation: Epoetin alfa mimics natural human erythropoietin, targeting specific erythropoietin receptors on red blood cell precursors.

B)Cell maturation: this stimulation triggers the division, growth and maturation of erythroid progenitor cells in the bone marrow.

C)Increased production: The bone marrow then produces a higher volume of healthy red blood cells, improving haemoglobin levels and the blood oxygen-carrying capacity .

 

  • Promotion of red blood cells in the bone marrow

RENOCEL 10000 IU is a man-made protein that tells once bone marrow to make more red blood cells . it contains recombinant human erythropoietin , which mimics a natural hormone produced by healthy kidneys.

  • Bone marrow stimulation: it targets the soft tissues inside the bones to boost the production of RBC
  • Improved oxygen: more red blood cells help carry oxygen through the body which reduces tiredness and weakness.

                    It is used in: a) kidney disease: Treats anaemia in adults and children with chronic kidney disease, especially those on dialysis .

b) chemotherapy: manages low red blood cell counts caused by certain cancer treatments.

c) HIV medicines: helps with anaemia linked to specific HIV therapies.

 

CONCLUSION

RENOCEL 10000 IU injection effectively treats anaemia associated with chronic kidney disease, chemotherapy or HIV by increasing red blood cell production. It reduces the need for blood transfusions and improve fatigue, though it requires the need for blood transfusion and improve fatigue, though it requires strict medical supervision due to risk of increased blood pressure and thrombosis.

 

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION : HOW DOES RENOCEL HELP TREAT ANEMIA?

RENOCEL injection is a prescription medicine containing epoetin alfa that treats anemia by telling the bone marrow to make more red blood cells.

 

QUESTION: WHY ARE HEMOGLOBIN LEVELS MONITORED?

RENOCEL 10000 IU is a medication that stimulates the bone marrow to produce RBC and treats anaemia. One must monitor their haemoglobin levels regularly during treatment to ensure the dose is safe and effective.

 

QUESTION: HOW SHOULD THE PRE-FILLED SYRINGE BE STORED?

Store RENOCEL 10000 IU pre-filled syringes in a refrigerator at 2 degree Celsius to 8 degree Celsius.

STORAGE GUIDELINES:

  • Refrigeration: keep the syringes in the refrigerator all the time.
  • No freezing: do not freeze the medicine or use a syringe that has been frozen
  • Light protection: keep the product in its original packaging to protect it from light.

REFRENCES:

1)https://www.mrmed.in/medicines/renocel-10000-iu-injection?srsltid=AfmBOooByw_wFqJyc2G-4ged2KFAIOHI-7nWaeygu98TDMi8NAB85Z2z

2)

https://www.medikabazaar.com/products/renocel-10000iu-injection?srsltid=AfmBOoqIDPgIMdy49cfrlF_CQE7NN8Vfn29m1z2DAd4LJ1nb1yAzxHSS

Posted on:

COMPLETE GUIDE TO EMTAF-B TABLETS

 

EMTAF-B tablets are an antiviral prescription medicine containing 25 mg of tenofovir alafenamide .  They are primarily used to treat chronic Hepatitis –B virus (HBV)  infection in adults and adolescent and can also form part of combination regimes for managing HIV infections. It plays a role in disease management by managing chronic hepatitis –B virus (HBV) infections and assisting in combination therapies for HIV. It works by stopping viral replication , which lowers viral load , reduces liver inflammation and prevents the severe long-term damage.

 

WHAT ARE EMTAF-B TABLETS  ?

EMTAF-B tablets are classified as antiviral medications, specifically belonging to the class of nucleotide reverse transcriptase (NtRTIs) or nucleotide analogs. They contain the active ingredient tenofovir alafenamide (25 mg).

Key classification:

  • Therapeutic category: Antiviral agent
  • Pharmacological class: Nucleotide analogue reverse transcriptase inhibitor (NtRI).
  • Active ingredient: Tenofovir alafenamide (25 mg)
  • Mechanism of Action: Tenofovir alafenamide enters target cells where it is hydrolyzed and transformed into its active form, tenofovir diphosphate (TFV-DP). The active TFV-DP compares with natural nucleotides to inhibit viral DNA polymerase . once incorporated into the DNA Chain, it stops further DNA synthesis , preventing the virus from multiplying and lowering the viral load.
  • Medicine is intended to be used: They work by lowering the amount of virus in the body and slowing liver damage , and they may also be used alongside other drugs to treat HIV. Take the dosage exactly according to once exact prescription and scheduled . Take the tablet with food to help the body absorb the medicine properly. Regular blood-test are required to check the liver and kidney function while on this therapy.

 

WHAT ARE THE USES OF EMTAF-B TABLETS?

Uses of EMTAF-B tablets are:

1)Approved medical indications

EMATAF-B tablets contain tenofovir alafenamide (25 MG) and are officially approved for the treatment of chronic hepatitis –B virus (HBV) infection in adults and adolescent aged 12 years and older. They work by lowering the viral load and reducing liver damaged. Some of the approved medical uses are:

  • Chronic Hepatitis B: managing long-term HBV infection in patients with compensated liver disease
  • HIV management : occasionally used as part of a combination regime with other antiretroviral for HIV-1 infection .

 

2)Role in managing the underlying conditions

 

EMTABF –B tablets manage chronic hepatitis B virus (HBV) and HIV infections by stopping the virus from multiplying in the body.it contains Tenofovir alafenamide, an antiviral medication . it changes into its active form inside cells to block viral DNA  production. It also lowers the viral load, which is the amount of virus present in the blood. It controls long-term liver infections , reduces liver inflammation, and lowers the risk of severe damage like scarring or cancer. It is used alongside other medicines to treat human immunodeficiency virus . it also target infected cells effectively while remaining gentler on bones and kidneys compared to older treatments.

 

3)Used alone or in combination with other medicines , when appropriate

EMTAFB tablets contain tenofovir alafenamide (25 mg) and are primarily used to treat chronic hepatitis B virus (HBV) infection, and when appropriate , they are combined with other antiretroviral medicines to manage HIV-1  infection . it slows the replication of hepatitis B virus, reducing the viral load in the blood and lowering the risk of  severe liver damage like cirrhosis.

  • When treating HIV, it is always used alongside other antireotroviral medications to prevent viral resistance and treatment failure.

 

WHAT ARE THE BENEFITS OF EMTAF-B TABLETS?

Benefits of EMTAF –B tablets are:

  • THERAPEUTIC BENEFITS
  • Reduces Viral Activity

Stops the virus from multiplying , which lowers the amount of virus In the blood to very low to undetectable levels.

  • Protects liver health

Decreases liver inflammation and lower the risk of severe damage,such as scarring or liver failure.

  • Supports immunity

Helps preserve the immune system and delays disease progression when managing HIV or viral co-infections.

  • Kidney and Bone safety

Uses a targeted design that delivers medicine directly to liver cells, reducing harmful exposure to one kidneys and bones compared to older antiviral treatments.

 

  • Role in controlling the underlying conditions

EMTAF –B  controls chronic hepatitis –B and HIV infections by stopping the virus from making copies of itself , which lowers the amount of virus in the blood and protects organ health.

 

  • For Hepatitis B: it decreases liver swelling and lowers the chance of dangerous scarring,known as cirrhosis or liver cancer.
  • For HIV: it tightens the work on one immune system so it can stay strong and fight off other sickness
  • Targeted safety : it moves directly into the target cells, which keeps the bones and kidneys safer than other antiviral drugs.

 

  • Expected treatment outcomes

EMTAF –B is expected treatment outcomes include effective viral suppression, reduced liver inflammation and a lower risk of long-term liver damage. Some of the expected treatment outcomes of EMTAF-B are:

  • Viral suppression: The medication successfully lowers the amount of the hepatitis B virus (HBV) in ones blood to undetectable or very low levels.
  • Reduced inflammation: it decreases active liver inflammation and helps improves overall liver function test over time.
  • Lower Disease Progression: long-term use minimizes the risk of severe complications, such as liver scarring or liver cancer
  • High barrier to resistance: clinical studies show a very low rate of the virus developing resistance to the medication during extended treatment.

 

Importance of adherence to prescribed therapy

Adherence strictly to prescribed therapy is essential to suppress the virus, prevent drug resistance, and protect the liver. Adherence matters to the following:

  • Sustained viral suppression: taking ones dose daily keeps steady drug levels in one’s body to stop the hepatitis B virus (HBV) from multiplying.
  • Preventing resistance: missing doses allows the virus to adapt, creating drug-resistant strains that make future treatment fail.
  • Avoiding liver flares: stopping treatment suddenly can trigger severe spikes in liver inflammation, known as hepatic flares or liver decomposition .
  • Lowering long-term risks: consistent use reduces the chances of developing severe complications like cirrhosis or liver cancer .

 

CONCLUSION

EMTAF-B tablets are concluded to be an effective, well-tolerated treatment for chronic Hepatitis B virus (HBV) infection, offering a safer renal profile than older formulations. The 25 mg tablets are used for long-term management to suppress viral replication with lower synthetic plasma concentration compared to TDF.

 

FREQUENTLY ASKED QUESTIONS (FAQs):

                      QUESTION: WHAT IS                      EMTAF-B IS USED FOR?

EMTAF-B tablets are primarily used to treat chronic hepatitis B virus (HBV) infection and as part of combination therapy for HIV-I infection.

QUESTION: HOW SHOULD EMTAF-B TABLETS BE TAKEN?

EMTAF-B tablets , which contains tenofovir,  alafenamide, are generally taken orally , usually with food, to ensure proper absorption. Taking the medicine at the same time each day helps maintain consistent levels in the body.

 

QUESTION: WHAT ARE THE ACTIVE INGREDIENTS IN EMTAF-B ?

EMTAF-B contain tenofovir alafenamide (25 mg) as their single active ingredient .

REFRENCES:

1)

https://www.1mg.com/drugs/emtaf-b-tablet-485638?wpsrc=Google+Organic+Search

2)https://www.truemeds.in/medicine/emtaf-b-25-mg-tablet-30-tm-tacr1-013301

Posted on:

PAZINIB 400 MG : A COMPREHENSIVE GUIDE TO CANCER TREATMENT 

PAZINIB 400 mg is a brand name prescription oral medication containing pazopanib, which belongs to a class of drugs called tyrosine kinase inhibitor . it is an anti-cancer treatment used for adults with advanced kidney cancer and specific types of advanced soft-tissue sarcoma. It treats advanced kidney cancer and specific types of advanced soft tissues sarcoma in adults by blocking tumor blood vessel growth and slowing cancer cell multiplication.

WHAT ARE PAZINIB 400 MG TABLETS?

PAZINIB 400 mg tablets contain pazopanib, an antineoplastic agent that is classified as a protein kinase inhibitor or tyrosine kinase inhibitor (TKI) .it function as a targeted biological therapyhttps://oncomshealthcare.com/complete-guide-to-biological-therapy-in-modern-medicine/ to slow tumor growth by blocking the blood vessel formation needed by cancer cells.

key classification:

• Pharmacological class: Tyrosine Kinase inhibitor/protein kinase inhibitor

• Therapeutic category: antineoplastic/anticancer agent(Targeted therapy)

• Active ingredient: Pazopanib (400mg)

• Primary indications: advanced renal cell carcinoma and advanced soft-tissue sarcoma

• Used in targeted cancer cell therapy: it is used as a targeted cancer cell therapy by blocking specific proteins that signal cancer cells to multiply and halts the formation of the blood vessels tumors need to grow.

• Mechanism of action: it inhibit tyrosine kinase by blocking VGEF receptors, PDGF receptors and c-kit. It prevents tumors from developing the blood vessel network required to supply oxygen and nutrients effectively starving the cancer cells. It also interfere with the internal signals driving cell division and proliferation.

WHAT ARE THE USES OF PAZINIB 400 MG TABLETS?

Uses of PAZINIB 400 mg tablets are:

1. Advanced renal cell carcinoma (RCC)

PAZINIB 400 mg is a targeted cancer therapy used to treat adults with advanced renal cell carcinoma . it act as a tyrosine kinase inhibitor ,blocking proteins that tumors needed to form blood vessels and grow , thereby slowing disease progression. It works by blocking vascular endothelial growth factors receptors (VEGFR) to cut off the blood supply feeding the tumor. It works in the following ways:

• Cell proliferation control: inhibits platelet-derived growth factor receptors (PDGFR) and c-kit to stop cancer cells from multiplying .

• First-line and follow –up treatment: used as an initial medical treatment or for paents who previously received cytokine therapies.

2. Advanced soft –tissue sarcoma (STS) in appropriate patients

PAZINIB 400 mg is a targeted cancer medicine used to treat specific adults with advanced soft tissue sarcoma (STS) who received prior chemotherapyhttps://oncomshealthcare.com/living-with-prostate-cancer-treatment-diet-lifestyle-tips/comprehensive-guide-to-chemotherapy-and-cancer-care/ , though 400 mg is frequently a reduced or staring dose for management of side effects or liver impairment rather than the standard initial full dose.

3. Use according to approved indications and oncological recommendations

PAZINIB 400 mg is a targeted multi-tyrosine-kinase inhibitor . its standard full starting dose is 800 mg once daily , meaning, a 400 mg dose typically represents a first-level dose reduction for managing toxicity or an adjustment for specific drug interactions, rather than the standard initial dose. It is first-line treatment for patients who received prior cytokine therapy and also used in treatment of adults who received prior chemotherapy .

HOW PAZINIB WORK?

PAZINIB 400 mg works as a targeted cancer therapy by blocking specific proteins called tyrosine kinase inhibitor that signals cancer cells to grow, multiply and form new blood vessels. By cutting off the tumor’s blood supply and stopping growth signals, it starves the cancer and slows its spread. It works in the following ways:

• Inhibition of vascular endothelial growth factor receptors(VEGFRs)

PZANIB 400 mg is an oral multi-targeted tyrosine kinase inhibitor that blocks vascular endothelial growth factors receptors . by inhibiting these receptors inside endotheial cells, it stops the signals that trigger new blood vessel growth. This cuts off the tumors blood supply ,starving the cancer cells of oxygen and nutrients. VEGFRS works by blocking ATP binding pazopanib fits into the intracellular ATP –binding pocket of the receptor tyrosine kinase receptor.

• Effect on other growth –factor receptor pathways

PAZANIB 400 mg blocks not only vascular endotheial growth factor receptors (VEGFR) but also other vital growth factor pathways involved in tumor growth, pericyte support, and blood vessel formation. Stem cell inhibitor interfers with cell survivals and proliferation signaling tied to specific tumors.

• Reduction of tumor blood-vessels formation (angiogenesis)

PAZANIB 400 mg reduces tumor blood vessel formation by blocking key signaling proteins like VGEFR , PDGFR and c-kit , thereby starving the tumor of oxygen and nutrients . VGEFR blocks vascular endothelial growth factor receptors 1,2 and 3 which stops endothelial cells from forming new blood vessels. It restricts blood supply, slowing cancer cell proliferation and inducing cell death in specific advanced solid tumors.

• Slowing cancer –cell growth and disease progression

PAZINIB 400 mg contains pazopanib, a targeted tyrosine kinase inhibitor, that slows cancer progression and tumor growth by blocking specific enzymes that promote cell division and cutting off the blood supply tumors need to survive. PAZINIB works by blocking vascular endothelial growth factor receptors (VEGFR) to prevent tumors from creating new blood vessels. It also disrupts platelet –derived growth factor receptors (PDGFR) and c-KIT to stop abnormal cell multiplication.

CONCLUSION

PAZINIB 400 mg is a targeted tyrosine kinase inhibitor prescribed to treat advanced kidney cancer and specific soft-tissues sarcomas. Clinical evaluation concludes that while it effectively slows tumor progression by blocking the blood vessels growth, thereby requires monitoring for hypertension, liver function and gastrointestinal side effects. It manages advanced renal cell carcinoma and selective advanced soft-tissue sarcomas in adults. It alo act as an anti-angiogenic agent blocking VEGF receptors to cut off the blood supply sustaining tumor growth. It is not a cure but significantly delays disease advancement and manage tumor-related burdens.

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS PANAZIB 400 MG USED FOR?

PAZANIB 400 mg contains PAZOPANIB, a targeted anti-cancer medication known as a tyrosine kinase inhibitor. it is used in adults to treat advanced kidney cancer (renal cell carcinoma), and certain types of advanced soft-tissue sarcoma who have received prior chemotherapy .

QUESTION: HOW DOES PAZOPANIB WORK?

PAZNIB 400 mg is a targeted cancer therapy that work as a tyrosine kinase inhibitor . it blocks specific proteins that signals cancer cells to multiply and stops tumors from building the new blood vessels they need to grow and survive.

QUESTION: WHY ARE LIVER-FUNCTION TEST REQUIRED?

Liver function test (LFT) are required during PAZINIB 400 mg consumption because the medication carries a significant risk of drug-induced liver injury and hepatotoxicity. It frequently causes elevated liver enzymes and bilirubin , which can become severe or life-threatening if unmonitored.

REFRENCES:

1)https://www.1mg.com/drugs/votrient-400mg-tablet-152287?wpsrc=Google+Organic+Search

2)https://m.indiamart.com/proddetail/pazopanib-tablets-400-mg-25859926448.html

Add to cart